New cancer clinical trial: Phase I Study of SHR9146 in Combination With SHR-1210 and With/Without Apatinib in Patients With Advanced Solid Tumors

Published on: April 09, 2018 at 12:00PM
Conditions:   Tumor, Solid;   Cancer, Metastatic;   Neoplasm Malignant
Interventions:   Drug: SHR9146+SHR-1210;   Drug: SHR9146+SHR-1210+Apatinib
Sponsor:   Jiangsu HengRui Medicine Co., Ltd.
Not yet recruiting
https://ift.tt/2GO004A